Orion
Sammeli Liikkanen is a seasoned professional in the pharmaceutical and digital medicine sectors, serving as the Director of Digital Medicine and Head of X Lab, as well as Chief Digital Officer at Orion Corporation. Prior experience includes a role in Special Operations at Morrr Ltd and a position as CS-Specialist within Orion Pharma R&D. Sammeli Liikkanen holds a Doctor of Philosophy (PhD) in Pharmacology and Drug Development from the University of Turku, attained between August 2020 and August 2023, and an Executive MBA in Leadership from the same institution, completed from 2008 to 2011.
This person is not in any teams
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.